The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125496381 12549638 1 I 2014 20160629 20160712 20160712 EXP US-BAYER-2016-131863 BAYER 0.00 F Y 0.00000 20160712 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125496381 12549638 1 PS CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 UNK 21473 MODIFIED-RELEASE FILM-COATED TABLET
125496381 12549638 2 SS ZITHROMAX AZITHROMYCIN DIHYDRATE 1 Subcutaneous UNK 0
125496381 12549638 3 C HUMIRA ADALIMUMAB 1 40 MG, UNK 0 40 MG
125496381 12549638 4 C SPIRONOLACTON SPIRONOLACTONE 1 UNK 0
125496381 12549638 5 C CEREBREX CALCIUM GLYCEROPHOSPHATECALCIUM PHOSPHATEGLUTAMIC ACIDVITAMIN B 1 UNK 0
125496381 12549638 6 C FUROSEMIDE. FUROSEMIDE 1 UNK 0
125496381 12549638 7 C IMURAN AZATHIOPRINE 1 UNK 0
125496381 12549638 8 C ATENOLOL. ATENOLOL 1 UNK 0
125496381 12549638 9 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 UNK 0
125496381 12549638 10 C OSTEO BI-FLEX CHONDROITIN SULFATE AGLUCOSAMINE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125496381 12549638 1 Bronchitis
125496381 12549638 2 Bronchitis
125496381 12549638 3 Crohn's disease
125496381 12549638 4 Fluid retention
125496381 12549638 5 Osteoarthritis
125496381 12549638 6 Fluid retention
125496381 12549638 7 Crohn's disease
125496381 12549638 8 Hypertension
125496381 12549638 9 Depression
125496381 12549638 10 Osteoarthritis

Outcome of event

Event ID CASEID OUTC COD
125496381 12549638 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125496381 12549638 Abdominal pain
125496381 12549638 Bronchitis
125496381 12549638 Candida infection
125496381 12549638 Depression
125496381 12549638 Diarrhoea
125496381 12549638 Dyskinesia
125496381 12549638 Gastric ulcer
125496381 12549638 Hiatus hernia
125496381 12549638 Memory impairment
125496381 12549638 Nausea
125496381 12549638 Parasomnia
125496381 12549638 Product use issue
125496381 12549638 Pyrexia
125496381 12549638 Rash pruritic
125496381 12549638 Sleep disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125496381 12549638 1 2014 2014 0
125496381 12549638 3 200809 2014 0